Delivery Order SPE2DB20D7059-SPE2DB25FGRJ0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,217.22 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg in a 28-tablet package. This non-set-aside, firm fixed price delivery order was competitively awarded and is scheduled for completion by August 28, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,437.99 for Junel FE 1 mg-20 mcg tablets (28-count), a hormonal contraceptive medication. The contract was competitively awarded without set-aside designation on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.56 to AmerisourceBergen Drug Corp for NORTREL 0.5-35-28 Tablet 28S, a contraceptive medication. The contract was awarded on August 14, 2025, under firm fixed-price terms with an ultimate completion date of August 15, 2025. This is a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Norethindrone 5 mg tablets (90-count units) with a contract ceiling value of $6,039.97. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of September 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.72 firm fixed-price delivery order is for the supply of norgestimate-ee 0.25-0.035 mg tablets, a medical product used for various healthcare applications. The contract has an ultimate completion date of March 4, 2025 and was awarded on March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This competitively awarded, non-set-aside contract carries a ceiling value of $11,276.65 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency Troop Support Medical awarded a $64,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Norgestimate and Ethinyl Estradiol. The order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA customers. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 14 to 15, 2023. No subcontractors or set...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,766.29 for Levonorgestrel 1.5mg tablets from the Medical Supply Chain, a division of the Defense Logistics Agency. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order is a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency Troop Support Medical awarded a $195.27 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the procurement of norgestimate and ethinyl estradiol. As the prime contractor, Amerisourcebergen Drug Corp will fulfill the order requirements under the contract's period of performance from August 10-11, 2023. No additional details were provided regarding subcontractors or the solicitation that initiated this delivery order. The...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGRJ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg contraceptive medication in a 28-day supply. This competitive, non-set-aside delivery order carries a ceiling value of $3,290.16 under firm fixed price terms, with an ultimate completion date of September 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated capability to fulfill federal healthcare supply requirements through open competition across a diverse portfolio of pharmaceutical products and therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/10/25 |